A, L., JJ, J., ER, A., RB, N., R, G., MD, P., & EJ, M. (2014). Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationA, Lucero-Acuña, Jeffery JJ, Abril ER, Nagle RB, Guzman R, Pagel MD, and Meuillet EJ. Nanoparticle Delivery of an AKT/PDK1 Inhibitor Improves the Therapeutic Effect in Pancreatic Cancer. Dove Medical Press, 2014.
MLA (8th ed.) CitationA, Lucero-Acuña, et al. Nanoparticle Delivery of an AKT/PDK1 Inhibitor Improves the Therapeutic Effect in Pancreatic Cancer. Dove Medical Press, 2014.
Warning: These citations may not always be 100% accurate.